Lana Medical Company (TADAWUL:9587)
Saudi Arabia flag Saudi Arabia · Delayed Price · Currency is SAR
3.400
+0.290 (9.32%)
Apr 29, 2026, 2:56 PM AST

Lana Medical Company Ratios and Metrics

Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025 FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
168132160115--
Market Cap Growth
7.43%-17.57%38.75%---
Enterprise Value
192141161120--
Last Close Price
3.112.442.962.13--
PE Ratio
62.2948.8712.83---
PS Ratio
1.821.431.902.37--
PB Ratio
2.582.022.622.36--
P/TBV Ratio
2.582.032.632.37--
P/OCF Ratio
--406.51112.52--
EV/Sales Ratio
2.091.531.922.47--
EV/EBITDA Ratio
17.6613.7114.43107.83--
EV/EBIT Ratio
37.0423.6719.03---
Debt / Equity Ratio
0.450.450.250.230.160.21
Debt / EBITDA Ratio
2.492.491.297.110.941.04
Debt / FCF Ratio
----15.15-
Net Debt / Equity Ratio
0.380.380.15-0.150.090.13
Net Debt / EBITDA Ratio
2.392.390.81-6.670.560.65
Net Debt / FCF Ratio
-2.37-2.37-2.433.068.50-0.43
Asset Turnover
0.790.790.940.700.68-
Inventory Turnover
9.099.0915.448.345.37-
Quick Ratio
1.111.111.472.383.344.52
Current Ratio
1.581.581.873.034.165.39
Return on Equity (ROE)
4.28%4.28%22.70%-4.00%12.34%-
Return on Assets (ROA)
3.16%3.16%5.92%-0.33%6.77%-
Return on Invested Capital (ROIC)
4.77%5.36%13.93%-0.79%11.00%13.24%
Return on Capital Employed (ROCE)
7.50%7.50%11.80%-0.60%12.40%14.80%
Earnings Yield
1.61%2.05%7.80%-1.67%--
FCF Yield
-6.17%-7.87%-2.33%-2.11%--
Buyback Yield / Dilution
---18.38%-1.37%-37.11%-
Source: S&P Capital IQ. Standard template. Financial Sources.